collection
Collections Adult Psychiatric Unit: Seclus...

Adult Psychiatric Unit: Seclusion and Restraints

in hopes of reducing the need for S&R events and to increase the efficacy of humane treatments while in locked seclusion and restraints

https://read.qxmd.com/read/11143833/impact-of-risperidone-on-seclusion-and-restraint-at-a-state-psychiatric-hospital
#21
JOURNAL ARTICLE
K N Chengappa, J Levine, R Ulrich, H Parepally, J S Brar, R Atzert, R Brienzo, A Gopalani
OBJECTIVE: To evaluate the impact of risperidone on seclusion and restraint in patients at a state psychiatric facility, shortly after risperidone's release. METHODS: Patients who were in the hospital for at least 3 months prior to receiving risperidone and subsequently received risperidone for at least 3 months formed the cohort. A mirror-image design was used with duration to a maximum of 1 year before and 1 year after initiation of risperidone. The hospital population that did not receive either risperidone or clozapine during the same time period was used for comparison of trends of seclusion and restraint...
November 2000: Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie
https://read.qxmd.com/read/24292685/multisite-study-of-an-evidence-based-practice-to-reduce-seclusion-and-restraint-in-psychiatric-inpatient-facilities
#22
MULTICENTER STUDY
Dow A Wieman, Teresita Camacho-Gonsalves, Kevin Ann Huckshorn, Stephen Leff
OBJECTIVE: This federally funded study examined implementation and outcomes of the Six Core Strategies for Reduction of Seclusion and Restraint (6CS) in 43 inpatient psychiatric facilities. METHODS: A prototype Inventory of Seclusion and Restraint Reduction Interventions (ISRRI) tracked fidelity over time. Outcome measures--seclusion and restraint events as percentages of total inpatient population and seclusion and restraint hours as percentages of total inpatient hours--conformed to licensed Behavioral Health Performance Measurement System specifications...
March 1, 2014: Psychiatric Services: a Journal of the American Psychiatric Association
https://read.qxmd.com/read/17568297/seclusion-and-restraint-in-patients-with-schizophrenia-clinical-and-biographical-correlates
#23
COMPARATIVE STUDY
Tilman Steinert, Gabriele Bergbauer, Peter Schmid, Ralf Peter Gebhardt
Seclusion and restraint represent adverse experiences that cause negative attitudes against psychiatric treatment and psychopathologic sequels such as posttraumatic stress disorder. We examined 117 consecutive admissions with schizophrenia, with an average of 8.7 previous admissions. Positive and Negative Syndrome Scale and Global Assessment of Functioning were obtained at admission and discharge, and traumatic events in the biography were recorded using the Posttraumatic Diagnostic Scale. Twenty-four men (42...
June 2007: Journal of Nervous and Mental Disease
https://read.qxmd.com/read/19956444/effectiveness-and-medication-acceptance-of-olanzapine-disintegrating-tablets-compared-to-standard-olanzapine-tablets-in-acutely-treated-psychiatric-patients
#24
JOURNAL ARTICLE
Jörg Czekalla, Thomas Wagner, Alexander Schacht, Michael Kluge, Bruce Kinon
BACKGROUND: This study compared effectiveness and acceptance of orally disintegrating olanzapine tablets (ODT) with standard-coated tablets (SOT) in acutely ill psychiatric patients admitted to psychiatric hospitals for emergency treatment. METHODS: Large, prospective, observational study at hospital emergency units across Germany in patients with a diagnosis or tentative diagnosis of acute schizophrenia treated with ODT or SOT. Clinical (CGI-S and CGI-I) outcomes, attitudes towards medication (Nursing Assessment of Medication Acceptance, NAMA) scale, suicidal ideation, and adverse events were assessed at start of treatment and after 2 weeks...
2007: Patient Preference and Adherence
https://read.qxmd.com/read/23422376/intramuscular-ziprasidone-versus-haloperidol-for-managing-agitation-in-chinese-patients-with-schizophrenia
#25
RANDOMIZED CONTROLLED TRIAL
Hongyan Zhang, Gang Wang, Jingping Zhao, Shiping Xie, Xiufeng Xu, Jianguo Shi, Hehuang Deng, Keqing Li, Chengge Gao, Xiaoping Wang, Douglas Vanderburg, Sharon Pan, Haiyun Tang, Liang Shu, Onur N Karayal
Intramuscular (IM) antipsychotics are preferred for efficient control of agitation symptoms. Previous studies have demonstrated that IM ziprasidone is efficacious and safe for treatment of agitation in schizophrenia. However, clinicians now recognize that racial differences may contribute to altered therapeutic response and tolerability. This study compared the efficacy and tolerability of IM ziprasidone versus IM haloperidol for the management of agitation in Chinese subjects with schizophrenia. Subjects with acute schizophrenia were randomized to either ziprasidone (n = 189, 10 to 20 mg as required up to a maximum of 40 mg/d) or haloperidol (n = 187, 5 mg every 4 to 8 hours to a maximum of 20 mg/d) for 3 days...
April 2013: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/24268565/risk-for-physical-restraint-or-seclusion-in-the-psychiatric-emergency-service-pes
#26
JOURNAL ARTICLE
Scott A Simpson, Jutta M Joesch, Imara I West, Jagoda Pasic
OBJECTIVE: We describe risk factors associated with patients experiencing physical restraint or seclusion in the psychiatric emergency service (PES). METHODS: We retrospectively reviewed medical records, nursing logs and quality assurance data for all adult patient encounters in a PES over a 12-month period (June 1, 2011-May 31, 2012). Descriptors included demographic characteristics, diagnoses, laboratory values, and clinician ratings of symptom severity. χ(2) and multivariate logistic regression analyses were performed...
2014: General Hospital Psychiatry
https://read.qxmd.com/read/17124642/initial-treatment-of-severe-acute-psychosis-with-fast-orally-disintegrating-risperidone-tablets
#27
MULTICENTER STUDY
C Normann, M Schmauss, N Bakri, M Gerwe, A Schreiner
INTRODUCTION: Although the use of atypical antipsychotics is the standard of care in the maintenance treatment of psychosis, most clinicians still rely on conventional neuroleptics to treat acutely agitated psychotic patients. The objective of this study was to evaluate the effectiveness and safety of a fast orally disintegrating tablet formulation of risperidone in the initial treatment of a large sample of very acutely ill psychotic patients. METHODS: In this multi-center, prospective, open-label observational trial, 191 schizophrenic patients were treated upon admission to hospital with fast orally disintegrating risperidone tablets for up to seven days...
November 2006: Pharmacopsychiatry
https://read.qxmd.com/read/11206599/intramuscular-ziprasidone-compared-with-intramuscular-haloperidol-in-the-treatment-of-acute-psychosis-ziprasidone-i-m-study-group
#28
RANDOMIZED CONTROLLED TRIAL
S Brook, J V Lucey, K P Gunn
BACKGROUND: This 7-day, randomized, open-label, multicenter, international study compared the efficacy and tolerability of intramuscular (i.m.) ziprasidone with haloperidol i.m. and the transition from i.m. to oral treatment in hospitalized patients with acute psychotic agitation (related to DSM-III-R diagnoses). METHOD: Patients received up to 3 days of flexible-dose ziprasidone i.m. (N = 90) or haloperidol i.m. (N = 42) followed by oral treatment to day 7. After an initial ziprasidone i...
December 2000: Journal of Clinical Psychiatry
https://read.qxmd.com/read/23602690/benzodiazepine-augmentation-of-antipsychotic-drugs-in-schizophrenia-a-meta-analysis-and-cochrane-review-of-randomized-controlled-trials
#29
REVIEW
Markus Dold, Chunbo Li, Donna Gillies, Stefan Leucht
Applying various psychopharmacological combination and augmentation strategies in schizophrenia is common clinical practice. This meta-analysis evaluated the efficacy of benzodiazepines added to antipsychotics. The Cochrane Schizophrenia Group trial register (until February 2011) and PubMed/Medline (until July 2012) were searched for randomized controlled trials (RCTs) with a minimum duration of one week that compared benzodiazepine augmentation of antipsychotics with a control group receiving antipsychotic monotherapy in schizophrenia and schizophrenia-like psychoses...
September 2013: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://read.qxmd.com/read/22461918/the-psychopharmacology-of-agitation-consensus-statement-of-the-american-association-for-emergency-psychiatry-project-beta-psychopharmacology-workgroup
#30
JOURNAL ARTICLE
Michael P Wilson, David Pepper, Glenn W Currier, Garland H Holloman, David Feifel
Agitation is common in the medical and psychiatric emergency department, and appropriate management of agitation is a core competency for emergency clinicians. In this article, the authors review the use of a variety of first-generation antipsychotic drugs, second-generation antipsychotic drugs, and benzodiazepines for treatment of acute agitation, and propose specific guidelines for treatment of agitation associated with a variety of conditions, including acute intoxication, psychiatric illness, delirium, and multiple or idiopathic causes...
February 2012: Western Journal of Emergency Medicine
https://read.qxmd.com/read/24980166/an-issue-of-equity-of-care-psychiatric-patients-must-be-treated-on-par-with-medical-patients
#31
JOURNAL ARTICLE
Leslie S Zun
No abstract text is available yet for this article.
July 2014: American Journal of Psychiatry
https://read.qxmd.com/read/15916448/pharmacological-management-of-acute-agitation
#32
REVIEW
John Battaglia
Acute agitation occurs in a variety of medical and psychiatric conditions, and when severe can result in behavioural dyscontrol. Rapid tranquillisation is the assertive use of medication to calm severely agitated patients quickly, decrease dangerous behaviour and allow treatment of the underlying condition. Intramuscular injections of typical antipsychotics and benzodiazepines, given alone or in combination, have been the treatment of choice over the past few decades. Haloperidol and lorazepam are the most widely used agents for acute agitation, are effective in a wide diagnostic arena and can be used in medically compromised patients...
2005: Drugs
https://read.qxmd.com/read/20473056/comparison-of-intramuscular-olanzapine-orally-disintegrating-olanzapine-tablets-oral-risperidone-solution-and-intramuscular-haloperidol-in-the-management-of-acute-agitation-in-an-acute-care-psychiatric-ward-in-taiwan
#33
RANDOMIZED CONTROLLED TRIAL
Wen-Yu Hsu, Si-Sheng Huang, Bo-Shyan Lee, Nan-Ying Chiu
INTRODUCTION: The purpose of this study was to compare efficacy and safety among intramuscular olanzapine, intramuscular haloperidol, orally disintegrating olanzapine tablets, and oral risperidone solution for agitated patients with psychosis during the first 24 hours of treatment in an acute care psychiatric ward. METHODS: Forty-two inpatients from an acute care psychiatric ward of a medical center in central Taiwan were enrolled. They were randomly assigned to 1 of the 4 treatment groups (10-mg intramuscular olanzapine, 10-mg olanzapine oral disintegrating tablet, 3-mg oral risperidone solution, or 7...
June 2010: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/22188043/seclusion-and-restraint-in-psychiatry-patients-experiences-and-practical-suggestions-on-how-to-improve-practices-and-use-alternatives
#34
JOURNAL ARTICLE
Raija Kontio, Grigori Joffe, Hanna Putkonen, Lauri Kuosmanen, Kimmo Hane, Matti Holi, Maritta Välimäki
PURPOSE: This study explored psychiatric inpatients' experiences of, and their suggestions for, improvement of seclusion/restraint, and alternatives to their use in Finland. METHODS: The data were collected by focused interviews (n= 30) and were analyzed with inductive content analysis. RESULTS: Patients' perspectives received insufficient attention during seclusion/restraint processes. Improvements (e.g., humane treatment) and alternatives (e...
January 2012: Perspectives in Psychiatric Care
https://read.qxmd.com/read/24492902/association-of-empathy-of-nursing-staff-with-reduction-of-seclusion-and-restraint-in-psychiatric-inpatient-care
#35
JOURNAL ARTICLE
Chin-Po Paul Yang, William A Hargreaves, Alan Bostrom
OBJECTIVE: Disruptive behavior leading to seclusion or restraint increases with patients in a high-acuity stage of mental illness who have histories of aggressive behavior. The study examined whether greater nursing staff empathy skills and motivation reduced use of seclusion and restraint and whether empathy training can further this effect. METHODS: In 1,098 nursing shifts in 2 six-month periods one year apart, hierarchical analyses examined the effects of nursing shift and patient characteristics, the effect for each shift of nurses' skill and motivation to use empathy, and whether empathy training reduced use of seclusion and restraint...
February 1, 2014: Psychiatric Services: a Journal of the American Psychiatric Association
https://read.qxmd.com/read/25022602/efforts-to-reduce-seclusion-and-restraint-use-in-a-state-psychiatric-hospital-a-ten-year-perspective
#36
JOURNAL ARTICLE
Alok Madan, Jeffrey J Borckardt, Anouk L Grubaugh, Carla Kmett Danielson, Stephen McLeod-Bryant, Harriet Cooney, Joan Herbert, Susan J Hardesty, B Christopher Frueh
OBJECTIVE: The authors previously demonstrated an 82.3% reduction in seclusion and restraint use at an inpatient psychiatric facility, largely attributable to changes to the physical environment. This study investigated whether the reduction was sustained over time. METHODS: This follow-up study examined archival data by using a longer preintervention baseline phase and examined the sustainability of intervention gains in the absence of a research agenda. Over ten years, 3,040 seclusion and restraint incidents were analyzed across 254,491 patient-days...
October 2014: Psychiatric Services: a Journal of the American Psychiatric Association
https://read.qxmd.com/read/23771480/cluster-randomized-controlled-trial-of-reducing-seclusion-and-restraint-in-secured-care-of-men-with-schizophrenia
#37
RANDOMIZED CONTROLLED TRIAL
Anu Putkonen, Satu Kuivalainen, Olavi Louheranta, Eila Repo-Tiihonen, Olli-Pekka Ryynänen, Hannu Kautiainen, Jari Tiihonen
OBJECTIVE: This randomized controlled trial studied whether seclusion and restraint could be prevented in the psychiatric care of persons with schizophrenia without an increase of violence. METHODS: Over the course of a year, 13 wards of a secured national psychiatric hospital in Finland received information about seclusion and restraint prevention. Four high-security wards (N=88 beds) for men with psychotic illness were then stratified by coercion rates and randomly assigned to two equal groups...
September 1, 2013: Psychiatric Services: a Journal of the American Psychiatric Association
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.